Follow
Michael L Garelja
Michael L Garelja
University of Otago, Department of Pharmacology and Toxicology
Verified email at otago.ac.nz
Title
Cited by
Cited by
Year
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
DL Hay, ML Garelja, DR Poyner, CS Walker
British journal of pharmacology 175 (1), 3-17, 2018
3212018
Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties
HA Watkins, M Chakravarthy, RS Abhayawardana, JJ Gingell, M Garelja, ...
Journal of Biological Chemistry 291 (22), 11657-11675, 2016
472016
CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists?
ML Garelja, CS Walker, DL Hay
British Journal of Pharmacology 179 (3), 454-459, 2022
342022
Molecular mechanisms of class B GPCR activation: insights from adrenomedullin receptors
ML Garelja, M Au, MA Brimble, JJ Gingell, ER Hendrikse, A Lovell, ...
ACS pharmacology & translational science 3 (2), 246-262, 2020
342020
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs
MJ Woolley, CA Reynolds, J Simms, CS Walker, JC Mobarec, ML Garelja, ...
Biochemical pharmacology 142, 96-110, 2017
342017
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, AA Mathie, ...
British journal of pharmacology 180, S23-S144, 2023
332023
Photoaffinity cross-linking and unnatural amino acid mutagenesis reveal insights into calcitonin gene-related peptide binding to the calcitonin receptor-like receptor/receptor …
J Simms, R Uddin, TP Sakmar, JJ Gingell, ML Garelja, DL Hay, ...
Biochemistry 57 (32), 4915-4922, 2018
272018
Pharmacological characterisation of mouse calcitonin and calcitonin receptor‐like receptors reveals differences compared with human receptors
ML Garelja, RL Bower, MA Brimble, S Chand, PWR Harris, ...
British journal of pharmacology 179 (3), 416-434, 2022
212022
A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond
ML Garelja, DL Hay
Headache: The Journal of Head and Face Pain 62 (9), 1093-1104, 2022
142022
A potent fluorescent calcitonin gene‐related peptide analogue enables visualization of receptor internalization
LR Yule, ML Garelja, ER Hendrikse, JJ Gingell, DR Poyner, PWH Harris, ...
Peptide Science 111 (6), e24126, 2019
102019
Pharmacological characterization and investigation of N-terminal loop amino acids of adrenomedullin 2 that are important for receptor activation
H Musa, ER Hendrikse, MA Brimble, ML Garelja, HA Watkins, PWR Harris, ...
Biochemistry 58 (32), 3468-3474, 2019
102019
Receptor activity modifying proteins have limited effects on the Class BG protein-coupled receptor calcitonin receptor-like receptor stalk
ML Garelja, CA Walker, A Siow, SH Yang, PWR Harris, MA Brimble, ...
Biochemistry 57 (8), 1410-1422, 2018
102018
Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors
ML Garelja, TI Alexander, A Bennie, M Nimick, J Petersen, CS Walker, ...
British Journal of Pharmacology 181 (1), 142-161, 2024
22024
Characterization of antibodies against receptor activity-modifying protein 1 (RAMP1): A cautionary tale
ER Hendrikse, TA Rees, Z Tasma, ML Garelja, A Siow, PWR Harris, ...
International journal of molecular sciences 23 (24), 16035, 2022
22022
Calcitonin Family Receptors
ML Garelja, DL Hay
Encyclopedia of Molecular Pharmacology, 1-6, 2020
12020
Molecular insights into the signalling of calcitonin receptor-like receptor: receptor activity-modifying protein complexes
M Garelja
PhD Thesis-University of Auckland, 2019
12019
Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia
TA Rees, Z Tasma, ML Garelja, SJ O’Carroll, CS Walker, DL Hay
The Journal of Headache and Pain 25 (1), 36, 2024
2024
The processing intermediate of human amylin, pro-amylin (1–48) has in vivo and in vitro bioactivity
G Mazzini, C Le Foll, CN Boyle, ML Garelja, A Zhyvoloup, MET Miller, ...
Biophysical Chemistry, 107201, 2024
2024
Potential Paracrine Interactions between CGRP and the AMY1 Receptor in the Parabrachial Nucleus and Amygdala of Rodents
LM Forrester, ML Garelja, LK Dalldorf, AM Dawson, AJ Leen, TA Rees, ...
CEPHALALGIA 43 (1 supp), 40-41, 2023
2023
Differential interaction of beta-arrestin with the CGRP and AMY1 receptors
T Alexander, M Garelja, D Hay
CEPHALALGIA 43 (1 supp), 180-180, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20